Is 2Seventy Bio Stock a Good Investment?
2Seventy Bio Investment Advice | TSVT |
- Examine 2Seventy Bio's financial health by looking at its balance sheet, income statement, and cash flow statement. Analyze key financial ratios, such as Price-to-Earnings (P/E), Price-to-Sales (P/S), and Price-to-Book (P/B), to determine whether the stock is fairly valued or over/undervalued.
- Research 2Seventy Bio's leadership team and their track record. Good management can help 2Seventy Bio navigate difficult times and make strategic decisions that benefit shareholders and increases its net worth.
- Consider the overall health of the Pharmaceutical Products space and any emerging trends that could impact 2Seventy Bio's business and its evolving consumer preferences.
- Compare 2Seventy Bio's performance and market position to its competitors. Analyze how 2Seventy Bio is positioned in terms of product offerings, innovation, and market share.
- Check if 2Seventy Bio pays a dividend and its dividend yield and payout ratio.
- Review what financial analysts are saying about 2Seventy Bio's stock and their price targets. However, remember that analysts' opinions can vary, and their predictions may not always be accurate.
It's important to note that investing in 2Seventy Bio stock, carries risks, and you should carefully consider your investment goals and risk tolerance before making any investment decisions. Also, remember that it's important for investors to have a long-term perspective and a well-diversified portfolio to manage the impact of stock market volatility on their investments. Below is a detailed guide on how to decide if 2Seventy Bio is a good investment.
Sell | Buy |
Strong Sell
Market Performance | OK | Details | |
Volatility | Dangerous | Details | |
Hype Condition | Stale | Details | |
Current Valuation | Overvalued | Details | |
Odds Of Distress | High | Details | |
Economic Sensitivity | Moves totally opposite to the market | Details | |
Investor Sentiment | Impartial | Details | |
Analyst Consensus | Not Available | Details | |
Financial Leverage | Not Rated | Details | |
Reporting Quality (M-Score) | Unavailable | Details |
Examine 2Seventy Bio Stock
Researching 2Seventy Bio's stock involves analyzing various aspects of the company and its industry to make an informed investment decision. The key areas to focus on are fundamentals, business model and competitive advantage. It is also important to analyze trends in revenue, net income, and cash flow, as well as key financial ratios, such as price-to-earnings (P/E), price-to-sales (P/S), and debt-to-equity (D/E). About 88.0% of the company shares are owned by institutional investors. The company has price-to-book ratio of 1.14. Typically companies with comparable Price to Book (P/B) are able to outperform the market in the long run. 2Seventy Bio recorded a loss per share of 1.83. The entity had not issued any dividends in recent years.
To determine if 2Seventy Bio is a good investment, evaluating the company's potential for future growth is also very important. This may include expanding into new markets, launching new products or services, or improving operational efficiency. Companies with strong growth prospects can be more attractive investments. This aspect of the research should be conducted in the context of the overall market and industry in which the company operates and should include an analysis of growth potential, competitive landscape, and any regulatory or economic factors that could impact the business. Some of the essential points regarding 2Seventy Bio's research are outlined below:
| 2Seventy Bio is way too risky over 90 days horizon | |
| 2Seventy Bio appears to be risky and price may revert if volatility continues | |
| 2Seventy Bio has high likelihood to experience some financial distress in the next 2 years | |
| The company reported the previous year's revenue of 100.39 M. Net Loss for the year was (217.57 M) with loss before overhead, payroll, taxes, and interest of (90.73 M). | |
| 2Seventy Bio currently holds about 357.93 M in cash with (166.86 M) of positive cash flow from operations. This results in cash-per-share (CPS) ratio of 9.45, which can makes it an attractive takeover target, given it will continue generating positive cash flow. | |
| Over 88.0% of the company shares are owned by institutional investors |
2Seventy Bio uses earnings reports to provide investors with an update of all three financial statements, including the income statement, the balance sheet, and the cash flow statement. Therefore, it is also crucial when considering investing in 2Seventy Bio. Every quarterly earnings report provides investors with an overview of sales, expenses, and net income for the most recent period. It also may provide a comparison to 2Seventy Bio's previous reporting period. The quarterly earnings reports are usually disseminated to the public via Form 10-Q, which is a legal document filed with the Securities and Exchange Commission every quarter.
| 21st of March 2024 Upcoming Quarterly Report | View | |
| 1st of May 2024 Next Financial Report | View | |
| 31st of December 2023 Next Fiscal Quarter End | View | |
| 21st of March 2024 Next Fiscal Year End | View | |
| 30th of September 2023 Last Quarter Report | View | |
| 31st of December 2022 Last Financial Announcement | View |
2Seventy Bio's market capitalization trends
The company currently falls under 'Small-Cap' category with a current market capitalization of 259.41 M.2Seventy Bio's profitablity analysis
The company has Profit Margin (PM) of (2.07) %, which may suggest that it does not properly executes on its current pricing strategies or is unable to control all of the operational costs. This is way below average. Similarly, it shows Operating Margin (OM) of (0.99) %, which suggests for every $100 dollars of sales, it generated a net operating loss of $0.99.Determining 2Seventy Bio's profitability involves analyzing its financial statements and using various financial metrics to determine if 2Seventy Bio is a good buy. For example, gross profit margin measures 2Seventy Bio's profitability after accounting for the cost of goods sold, while net profit margin measures profitability after accounting for all expenses. Other important metrics include return on assets, return on equity, and free cash flow. By reviewing multiple sources and metrics, you can gain a complete picture of 2Seventy Bio's profitability and make more informed investment decisions.
Please note, the imprecision that can be found in 2Seventy Bio's accounting process means that the reasonable investor should take a skeptical approach toward the financial statement analysis of 2Seventy Bio. Check 2Seventy Bio's Beneish M Score to see the likelihood of 2Seventy Bio's management manipulating its earnings.
Basic technical analysis of 2Seventy Stock
As of the 20th of March, 2Seventy Bio shows the mean deviation of 4.78, and Risk Adjusted Performance of 0.1071. Relative to fundamental indicators, the technical analysis model gives you tools to check practical technical drivers of 2Seventy Bio, as well as the relationship between them.2Seventy Bio's insider trading activities
Some recent studies suggest that insider trading raises the cost of capital for securities issuers and decreases overall economic growth. Trading by specific 2Seventy Bio insiders, such as employees or executives, is commonly permitted as long as it does not rely on 2Seventy Bio's material information that is not in the public domain. Local jurisdictions usually require such trading to be reported in order to monitor insider transactions. In many U.S. states, trading conducted by corporate officers, key employees, directors, or significant shareholders must be reported to the regulator or publicly disclosed, usually within a few business days of the trade. In these cases 2Seventy Bio insiders are required to file a Form 4 with the U.S. Securities and Exchange Commission (SEC) when buying or selling shares of their own companies.
2Seventy Bio's Outstanding Corporate Bonds
2Seventy Bio issues bonds to finance its operations. Corporate bonds make up one of the largest components of the U.S. bond market, which is considered the world's largest securities market. 2Seventy Bio uses the proceeds from bond sales for a wide variety of purposes, including financing ongoing mergers and acquisitions, buying new equipment, investing in research and development, buying back their own stock, paying dividends to shareholders, and even refinancing existing debt. Most 2Seventy bonds can be classified according to their maturity, which is the date when 2Seventy Bio has to pay back the principal to investors. Maturities can be short-term, medium-term, or long-term (more than ten years). Longer-term bonds usually offer higher interest rates but may entail additional risks.
| Dana 575 percent Corp BondUS235822AB96 | View | |
| US90138FAC68 Corp BondUS90138FAC68 | View | |
| US90138FAD42 Corp BondUS90138FAD42 | View | |
| MPLX LP 4125 Corp BondUS55336VAK61 | View | |
| MPLX LP 4875 Corp BondUS55336VAJ98 | View | |
| MPLX LP 52 Corp BondUS55336VAL45 | View | |
| Morgan Stanley 3591 Corp BondUS61744YAK47 | View | |
| Morgan Stanley 3971 Corp BondUS61744YAL20 | View |
Understand 2Seventy Bio's technical and predictive indicators
Using predictive indicators to make investment decisions involves analyzing 2Seventy Bio's various financial and market-based factors to help forecast future trends and identify investment opportunities. Select the indicators that are most relevant to your investment strategy. Each indicator has its own strengths and weaknesses, so it's essential to combine multiple indicators to get a more comprehensive view of the market and reduce the risk of making poor decisions based on limited data.
| Risk Adjusted Performance | 0.1071 | |||
| Market Risk Adjusted Performance | (1.08) | |||
| Mean Deviation | 4.78 | |||
| Semi Deviation | 3.88 | |||
| Downside Deviation | 4.9 | |||
| Coefficient Of Variation | 905.94 | |||
| Standard Deviation | 10.91 | |||
| Variance | 119.0 | |||
| Information Ratio | 0.1163 | |||
| Jensen Alpha | 1.11 | |||
| Total Risk Alpha | 2.12 | |||
| Sortino Ratio | 0.2591 | |||
| Treynor Ratio | (1.09) | |||
| Maximum Drawdown | 76.79 | |||
| Value At Risk | (7.43) | |||
| Potential Upside | 7.31 | |||
| Downside Variance | 23.98 | |||
| Semi Variance | 15.06 | |||
| Expected Short fall | (6.31) | |||
| Skewness | 5.86 | |||
| Kurtosis | 41.0 |
| Risk Adjusted Performance | 0.1071 | |||
| Market Risk Adjusted Performance | (1.08) | |||
| Mean Deviation | 4.78 | |||
| Semi Deviation | 3.88 | |||
| Downside Deviation | 4.9 | |||
| Coefficient Of Variation | 905.94 | |||
| Standard Deviation | 10.91 | |||
| Variance | 119.0 | |||
| Information Ratio | 0.1163 | |||
| Jensen Alpha | 1.11 | |||
| Total Risk Alpha | 2.12 | |||
| Sortino Ratio | 0.2591 | |||
| Treynor Ratio | (1.09) | |||
| Maximum Drawdown | 76.79 | |||
| Value At Risk | (7.43) | |||
| Potential Upside | 7.31 | |||
| Downside Variance | 23.98 | |||
| Semi Variance | 15.06 | |||
| Expected Short fall | (6.31) | |||
| Skewness | 5.86 | |||
| Kurtosis | 41.0 |
Consider 2Seventy Bio's intraday indicators
2Seventy Bio intraday indicators are useful technical analysis tools used by many experienced traders. Just like the conventional technical analysis, daily indicators help intraday investors to analyze the price movement with the timing of 2Seventy Bio stock daily movement. By combining multiple daily indicators into a single trading strategy, you can limit your risk while still earning strong returns on your managed positions.
2Seventy Bio time-series forecasting models is one of many 2Seventy Bio's stock analysis techniques aimed to predict future share value based on previously observed values. Time-series forecasting models ae widely used for non-stationary data. Non-stationary data are called the data whose statistical properties e.g. the mean and standard deviation are not constant over time but instead, these metrics vary over time. These non-stationary 2Seventy Bio's historical data is usually called time-series. Some empirical experimentation suggests that the statistical forecasting models outperform the models based exclusively on fundamental analysis to predict the direction of the market movement and maximize returns from investment trading.
2Seventy Stock media impact
Far too much social signal, news, headlines, and media speculation about 2Seventy Bio that are available to investors today. That information is available publicly through 2Seventy media outlets and privately through word of mouth or via 2Seventy internal channels. However, regardless of the origin, that massive amount of 2Seventy data is challenging to quantify into actionable patterns, especially for investors that are not very sophisticated with ever-evolving tools and techniques used in the investment management field.
A primary focus of 2Seventy Bio news analysis is to determine if its current price reflects all relevant headlines and social signals impacting the current market conditions. A news analyst typically looks at the history of 2Seventy Bio relative headlines and hype rather than examining external drivers such as technical or fundamental data. It is believed that price action tends to repeat itself due to investors' collective, patterned thinking related to 2Seventy Bio's headlines and news coverage data. This data is often completely overlooked or insufficiently analyzed for actionable insights to drive 2Seventy Bio alpha.
2Seventy Bio Corporate Management
| Teresa JD | General VP | Profile | |
| Susan AbuAbsi | Chief Officer | Profile | |
| DPHIL Phil | Chief Officer | Profile | |
| Anna TruppelHartmann | Chief Officer | Profile | |
| Victoria Eatwell | Chief Officer | Profile | |
| Steven Shamah | Head Research | Profile |
Additional Tools for 2Seventy Stock Analysis
When running 2Seventy Bio's price analysis, check to measure 2Seventy Bio's market volatility, profitability, liquidity, solvency, efficiency, growth potential, financial leverage, and other vital indicators. We have many different tools that can be utilized to determine how healthy 2Seventy Bio is operating at the current time. Most of 2Seventy Bio's value examination focuses on studying past and present price action to predict the probability of 2Seventy Bio's future price movements. You can analyze the entity against its peers and the financial market as a whole to determine factors that move 2Seventy Bio's price. Additionally, you may evaluate how the addition of 2Seventy Bio to your portfolios can decrease your overall portfolio volatility.